Assessment of knowledge, attitude and practice to ward prostate screening among older men attending urology department at Bugando medical centre Mwanza Tanzania.
Material type:
TextPublisher number: Wurzburg Road 35, BMC Premises, Post Code: 33102: P. O. Box 1464, Mwanza – Tanzania: Phone: +255 28 298 3384: Fax: +255 28 298 3386: Email: vc@bugando.ac.tz: www.bugando.ac.tzLanguage: English Language: Kiswahili Publication details: Mwanza, Tanzania: Catholic University of Health and Allied Sciences [CUHAS – Bugando] : ©2023Description: vii; 23 Pages; Includes References and Appendices Subject(s): Summary:
Introduction:
Background information: Prostate cancer is the malignant neoplasm of the prostate gland prostate is a common public health problem worldwide, with developing countries accounting for majority of cases. As time goes there is greater global attention due to the increasing incidence of prostate cancer. In 2020 more than 1.4 million new cases of prostate cancer were diagnosed (1). 1 in 8 men will be diagnosed in their life time, and about 1 in 41 men with prostate cancer dies (2).
Prostate cancer can result in serious long term complications including metastasis (that is can spread to adjacent organ like bladder and bones), incontinence, infertility, sexual dysfunction, prostate cancer have also serious physical, psychological and social consequence, negatively impacting on social and economic well-being of affected persons (3).
The risk factor for developing cancer is older age most common above 50 years, race black are mostly likely, family history (such as parent, child, sibling also risk increases when have breast cancer gene (BRCA 1 or BRCA 2 ), obesity and it also attributed by the lack of knowledge about prostate cancer (3).
Prostate cancer screening is detecting a cancer before the symptoms appear, there are two major ways of screening which are digital rectal examination (DRE) and prostate specific antigen (PSA).
DRE procedure done by a doctor inserting a lubricated gloved finger into patients rectum to feel for lumps, enlargements, or area of hardness that might indicates prostate cancer, it last less than a minutes while uncomfortable should cause no pain (4).
PSA is blood test used primarily to screen for prostate, 4.0ng/ml if it became above is alarming.
| Item type | Current library | Collection | Status | Barcode | |
|---|---|---|---|---|---|
| UNDERGRADUATE DISSERTATIONS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | NFIC | 1 | CUHAS/MD/4002512/T/1 |
Introduction:
Background information: Prostate cancer is the malignant neoplasm of the prostate gland prostate is a common public health problem worldwide, with developing countries accounting for majority of cases. As time goes there is greater global attention due to the increasing incidence of prostate cancer. In 2020 more than 1.4 million new cases of prostate cancer were diagnosed (1). 1 in 8 men will be diagnosed in their life time, and about 1 in 41 men with prostate cancer dies (2).
Prostate cancer can result in serious long term complications including metastasis (that is can spread to adjacent organ like bladder and bones), incontinence, infertility, sexual dysfunction, prostate cancer have also serious physical, psychological and social consequence, negatively impacting on social and economic well-being of affected persons (3).
The risk factor for developing cancer is older age most common above 50 years, race black are mostly likely, family history (such as parent, child, sibling also risk increases when have breast cancer gene (BRCA 1 or BRCA 2 ), obesity and it also attributed by the lack of knowledge about prostate cancer (3).
Prostate cancer screening is detecting a cancer before the symptoms appear, there are two major ways of screening which are digital rectal examination (DRE) and prostate specific antigen (PSA).
DRE procedure done by a doctor inserting a lubricated gloved finger into patients rectum to feel for lumps, enlargements, or area of hardness that might indicates prostate cancer, it last less than a minutes while uncomfortable should cause no pain (4).
PSA is blood test used primarily to screen for prostate, 4.0ng/ml if it became above is alarming.
There are no comments on this title.
Click on an image to view it in the image viewer